Advanced Manufacturing

Innovation District (AMIDS)

Based in Renfrewshire, the Advanced Manufacturing Innovation District Scotland (AMIDS) stands as a beacon of manufacturing innovation, solidifying its position as Scotland’s premier hub for advanced manufacturing. Designed to foster collaboration and drive technological advancements, AMIDS is where bold, visionary companies converge to redefine the future of manufacturing.

At the core of AMIDS are key institutions like the National Manufacturing Institute Scotland (NMIS) and the Medicines Manufacturing Innovation Centre. These centres work alongside major industry players such as Rolls Royce, Thermo Fisher Scientific, Peak Scientific, Terumo Aortic, and Doosan Babcock, creating a vibrant community focused on innovation.

Strategically located adjacent to Glasgow Airport, AMIDS offers unparalleled connectivity, making it an ideal investment location for businesses seeking global reach. The district’s proximity to the airport, Scotland’s largest charter hub, makes it easy for companies to collaborate internationally and access worldwide markets. The district also benefits from a highly skilled workforce, with strong support from both the Scottish and UK governments, highlighting the crucial role that advanced manufacturing plays in Scotland’s economic growth.

The National Manufacturing Institute Scotland (NMIS) is pioneering the future of manufacturing by driving innovation and boosting productivity. Through its expanding network of world-class R&D facilities, NMIS collaborate with businesses of all sizes across Scotland, the UK, and globally, offering cutting-edge technology solutions to ensure their success. NMIS is an evolution of the University of Strathclyde’s Advanced Forming Research Centre, and also encompasses the Lightweight Manufacturing Centre, Digital Factory, Manufacturing Skills Academy, and the soon-to-open Digital Process Manufacturing Centre. It is part of a highly connected international network that includes being part of the High Value Manufacturing (HVM) Catapult.

 

 

Established in 2018, The Medicines Manufacturing Innovation Centre (MMIC) is a collaborative initiative between CPI, the University of Strathclyde, UK Research & Innovation, Scottish Enterprise, and founding industry partners AstraZeneca and GSK. Dedicated to advancing pharmaceutical manufacturing, this £88 million state-of-the-art facility consolidates world-leading science and technology expertise. MMIC aims to significantly enhance the sustainability of medicine manufacturing.

“This flagship facility – which has sustainability at its heart – is a unique part of Scotland’s manufacturing innovation ecosystem. It will play a leading role in developing advanced manufacturing, industry 4.0 capability and cross-sectoral research and innovation activity in Scotland, the UK and beyond.”

Professor Sir Jim McDonald, Principal & Vice-Chancellor of the University of Strathclyde


Last Updated: Sept 2024

Get In Touch

If you would like to reach out to discuss anything from the above case study, please get in touch. Let us know if you would like to discuss contributing to the case studies we currently profile.